DR. REDDY’S LABORATORIES LIMITED Deferred Tax Expense Income
DR. REDDY’S LABORATORIES LIMITED (RDY) reported Deferred Tax Expense Income of -INR 3.04 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-06.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2025-06-06
| Period end | Deferred Tax Expense Income 12 month |
|---|---|
| 2025-03-31 | -3.04B INR 20-F · filed 2025-06-06 |
| 2024-03-31 | -3.27B INR 20-F · filed 2025-06-06 |
| 2023-03-31 | 2.44B INR 20-F · filed 2025-06-06 |
| 2022-03-31 | 2.32B INR 20-F · filed 2024-06-12 |
| 2021-03-31 | 1.00B INR 20-F · filed 2023-06-13 |
| 2020-03-31 | -8.08B INR 20-F · filed 2022-06-27 |
| 2019-03-31 | -1.06B INR 20-F · filed 2021-06-30 |
| 2018-03-31 | 2.76B INR 20-F · filed 2020-06-15 |
| 2017-03-31 | -480.00M INR 20-F · filed 2019-06-03 |
| 2016-03-31 | -250.00M INR 20-F · filed 2018-07-12 |